Clinical Trials List
2015-05-01 - 2018-12-31
Phase II
Terminated7
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Kelvin Kunchih Tsai Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hui-Hua Hsiao Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Jaw-Yuan Wang Division of General Surgery
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chung-Pin Li Division of General Internal Medicine
- Ming-Huang Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林育麟 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
44 participants
-
Global
0 participants
